This booklet provides comprehensive information on hepatitis C, detailing its impact on liver health, modes of transmission, symptoms, and the importance of testing and treatment. The booklet outlines the progression from acute to chronic infection, potential liver complications, and available diagnostic tests.
Contact organization for eligibility
This journal discusses the integration of hepatitis C management into primary care as a key strategy for eliminating the disease. It examines barriers to care, the role of direct-acting antivirals, and the importance of screening and treatment within primary care settings.
Contact organization for eligibility
Contact organization for eligibility
Contact organization for eligibility
This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.
This journal compares the effectiveness of Heplisav-B and standard hepatitis B vaccines as boosters for healthcare workers with low immunity to hepatitis B, measured by anti-HBs antibody levels. Results show that Heplisav-B offers a significantly higher seropositivity rate (99.4%) compared to the standard vaccine (92.7%).
Contact organization for eligibility
Contact organization for eligibility
